“I think the brand is very strong and the quality of people is very strong,” says Crowell, Weedon & Co.'s James D. Ragan.
Ragan, a senior equity analyst, told Benzinga that this was obviously a tremendous loss and a sad day. But from a company standpoint, he thinks that Apple AAPL did a good job this year indicating that Jobs' health was deteriorating.
“The company is prepared to move on without him,” said Ragan. “I think there's a product road map for the next few years.” Other analysts agree.
“[There is a] lot of growth left at Apple,” said Ragan, adding that the international market is just being tapped. “[The] stock is still relatively undervalued.”
Follow me @LouisBedigian
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorLong IdeasShort IdeasAnalyst RatingsTechTrading IdeasAppleCrowellJames D. RaganSteve JobsWeedon & Co.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in